Vitamin A Deficiency Is Associated with Increased Risk of Acute Graft Versus Host Disease in Children Dana T. Lounder, MD, Sonata Jodele, MD, Pooja Khandelwal,

Slides:

Advertisements

Similar presentations

Topical Ruxolitinib Protects LGR5+ Stem Cells in the Hair Follicle and Ameliorates Skin Graft-Versus-Host Disease Shuichiro Takahashi, MD, Daigo Hashimoto,

Advertisements

BK Viremia Precedes Hemorrhagic Cystitis in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Benjamin L. Laskin, Michelle Denburg,

Stephanie J. Lee, Loretta A. Williams

Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T-Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87% Pooja.

Phase 1 Study of Maraviroc As Acute Graft-Versus-Host Disease Prophylaxis in Pediatrics Pooja Khandelwal, MD, Tsuyoshi Fukuda, PhD, Ashley Teusink, PharmD,

How to Treat MDS without Stem Cell Transplantation

Kristen M. Coleman, RN, BSN, Stella M

Biology of Blood and Marrow Transplantation

Graft-Versus-Host Disease and Survival after Cord Blood Transplantation for Acute Leukemia: A Comparison of Japanese versus White Populations Yachiyo.

Liver Transplantation for Hepatic Graft-Versus-Host-Disease: A United Network for Organ Sharing (UNOS) Database Study Shahrukh Hashmi, MD MPH, Timucin.

IL-12hi Rapamycin-Conditioned Dendritic Cells Mediate IFN-γ-Dependent and Fas- Supported Apoptosis of Alloreactive CD4+ T Cells and Inhibit Graft-Versus-Host.

Sympathectomy Protects Denervated Skin from Graft-Versus-Host Disease

Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma Brian Hess, MD, Kathryn Trinkaus, Ph.D.,

Acute Graft-Versus-Host Disease in the Setting of T Cell Depletion: Validation of a New Agvhd Risk Score Hayder Saeed, MD, Stacey Slone, MS, Swati Yalamanchi,

Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)

Implementation of Post-Transplant Assessment Tools for Improved Accuracy of Graft- Versus-Host Disease Reporting Madhu Ragupathi, Jaskiran Kaur, Luda.

Gregory Wallace, DO, Sonata Jodele, MD, Kasiani C

High Risk HLA Allele for Severe Acute Graft-Versus-Host-Disease and Mortality in Unrelated Donor Hematopoietic Stem Cell Transplantation Satoko Morishima,

A Genetic Modifier of the Gut Microbiome Influences the Risk of Graft-versus-Host Disease and Bacteremia After Hematopoietic Stem Cell Transplantation

Pharmacogenetic Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplants Ashley Teusink,

Let Them Eat! Comparing a Neutropenic Diet to a Food Safety Based Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) Cynthia.

Early Soluble ST2 Elevation Predicts Future Left Ventricular Systolic Dysfunction after Stem Cell Transplant Christopher E. Dandoy, MD, MSc, Thomas D.

Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant Christopher E. Dandoy, MD, MSc, Abigail Pate, Mikako Warren,

Stephanie J. Lee, Loretta A. Williams

Recent Decrease in Acute Graft-versus-Host Disease in Children with Leukemia Receiving Unrelated Donor Bone Marrow Transplants Stella M. Davies, Dan.

Pauline A. Daniels, DO, Stella M

Pulse Cyclophosphamide for Steroid-Refractory Chronic Graft-Versus-Host Disease Nelson J. Chao, MD, MBA, Yevgeniya Gora Foster, MD, Krista Rowe, RN, MSN,

Lymphocyte Phenotype during Therapy for Acute Graft-versus-Host Disease: A Brief Report from BMT-CTN 0302 Javier Bolaños-Meade, Juan Wu, Brent R. Logan,

Role of the Mycobiome in Human Acute Graft-versus-Host Disease

A Single Ultra High Dose of Vitamin D is Safe and Feasible in Early Peri-Transplant Period to Prevent Vitamin D Deficiency in Pediatric HSCT Recipients

Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation—Results from a Single-Center Observational Study

Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation Ashley Teusink,

Gregory Wallace, Sonata Jodele, Jonathan Howell, Kasiani C

Helicobacter pylori Infection and Graft-versus-Host Disease

Sleep: An Unrecognized Casualty of Stem Cell Transplant

Seth Joshua Rotz, Nathan Luebbering, Bradley P. Dixon, Christopher E

A Novel Strategy in Managing Post-Liver Transplant Acute Graft-Versus-Host-Disease: The New Era (T)Rojan Horse Zeyad Kanaan, MD, William Tse, MD, FACP

Priscila Badia, Heidi Andersen, David Haslam, Adam S

Increased Vitamin D Binding Protein Levels Are Associated with Improved Overall Survival Following Bone Marrow Transplant in Children Nathan Luebbering,

Graft-Versus-Host Disease Targets Granulosa Cell of Ovarian Follicle and Causes Infertility after Allogeneic Hematopoietic Stem Cell Transplantation

Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning

Endothelial Injury, Neutrophil Extracellular Traps, and Complement Activation in Thrombotic Microangiopathy and GVHD Nicholas J. Gloude, Sonata Jodele,

Paul J. Martin, Terry Furlong, Scott D. Rowley, Steven A

Treatment of Severe Refractory Acute Graft-versus-Host Disease of the Gastrointestinal Tract with Campath-1H Alessandro Busca, Franco Locatelli, Elisabetta.

Biology of Blood and Marrow Transplantation

Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients Pooja Khandelwal, Sabine Mellor-Heineke, Najibah.

Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing Benjamin.

Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients.

A Pharmacokinetic and Pharmacodynamic Study of Maraviroc as Acute Graft-versus- Host Disease Prophylaxis in Pediatric Allogeneic Stem Cell Transplant Recipients.

Feasibility of Treating Post-Transplantation Minimal Residual Disease in Children with Acute Leukemia Nirali N. Shah, Michael J. Borowitz, Nancy C. Robey,

Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease.

Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant.

Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT Javier El-Bietar, MD, Mikako Warren, MD, Christopher.

Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan Yasuyuki Arai, MD, Junya Kanda, MD, Hideki.

Myeloablative Transplantation using either Cord Blood or Bone Marrow leads to Immune Recovery, High Long-Term Donor Chimerism and Excellent Survival in.

Sonata Jodele, Kejian Zhang, Christopher E. Dandoy, Kasiani C

Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data Brent R. Logan, Mei-Jie Zhang,

Mohammad Alhyari, M. D. , Aymen Bukannan, M. D. , Kimberly Brown, M. D

Diarrhea during the Conditioning Regimen Is Correlated with the Occurrence of Severe Acute Graft-versus-Host Disease through Systemic Release of Inflammatory.

Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft- versus-Host Disease: A Scoping Review of the Evidence Mina Rizk, Madeline.

Redesigning Care to Lower Episode Costs in Bone Marrow Transplantation

Calcinuerin-Inhibitor (CI) Free Graft-Versus-Host Disease (GvHD) Prophylaxis: Its Effects on Magnesium, Renal Function, and the Cost of Care Marlee Muilenburg,

Therapeutic Immunosuppression Concentrations on Day 0 and the Development of Acute Graft Versus Host Disease (GVHD) in Hematopoietic Stem Cell Transplantation.

Preengraftment Syndrome after Unrelated Cord Blood Transplant Is a Strong Predictor of Acute and Chronic Graft-versus-Host Disease Haydar Frangoul, Li.

C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall.

Low Serum Levels of Total Rabbit-IgG Is Associated with Acute Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation:

IL-8 Levels Early after Bone Marrow Transplant are Associated with Later Complications of Stem Cell Transplantation Nikhil Dole, Nathan Luebbering, Nicholas.

Cardiac Dysfunction after Stem Cell Transplantation: Can Peritransplant Cardiac Troponin-I Predict Future Issues? Seth Joshua Rotz, MD, Thomas D. Ryan,

Graft Versus Leukemia Effect Is Overestimated in Studies with High Rates of Graft Versus Host Disease Related Mortality: A Simulation Study Murtadha.

Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory- Confirmed Bloodstream Infections after Stem Cell Transplantation Christopher.

Presentation transcript:

Vitamin A Deficiency Is Associated with Increased Risk of Acute Graft Versus Host Disease in Children Dana T. Lounder, MD, Sonata Jodele, MD, Pooja Khandelwal, MD, Christopher E. Dandoy, MD, MSc, Gregory Wallace, DO, Adam Lane, PhD, Cynthia B. Taggart, RD, LD, Ashley Teusink, PharmD, MBA, BCPS, Kelly E. Lake, BS, Anna Maria Holdcroft, MS, Stella M. Davies, MBBS, PhD Biology of Blood and Marrow Transplantation Volume 22, Issue 3, Pages S94-S95 (March 2016) DOI: 10.1016/j.bbmt.2015.11.395 Copyright © 2016 Terms and Conditions

Figure 1 Cumulative Incidence of Grade 2-4 GVHD based on vitamin A level above and below the median at day +30. Biology of Blood and Marrow Transplantation 2016 22, S94-S95DOI: (10.1016/j.bbmt.2015.11.395) Copyright © 2016 Terms and Conditions

Figure 2 Cumulative Incidence of GI GVHD based on vitamin A level above and below the median at day +30. Biology of Blood and Marrow Transplantation 2016 22, S94-S95DOI: (10.1016/j.bbmt.2015.11.395) Copyright © 2016 Terms and Conditions

Figure 3 TRM based on vitamin A levels above and below the median at Day +30. Biology of Blood and Marrow Transplantation 2016 22, S94-S95DOI: (10.1016/j.bbmt.2015.11.395) Copyright © 2016 Terms and Conditions